Rituxan (rituximab) - Roche
Isolated Immunotactoid Glomerulonephritis Without Systemic Hematologic Disease (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #PUB200; "In this case, the patient was ultimately treated with Rituximab and demonstrated net improvement in proteinuria. Careful longitudinal surveillance remains essential, as an underlying hematologic disorder may emerge over time." 
Chronic Kidney Disease • Glomerulonephritis • Hematological Disorders • Immunology • Lupus Nephritis • Monoclonal Gammopathy • Nephrology • Renal Disease
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4556543
 
Eliezer Dade; Cinthya Carolina Aviles Riascos; Parham Eftekhari
 
Oct 2, 2026
 
Prev Next